MedPath
NMPA Approval

Erythromycin Ethylsuccinate Granules

国药准字H33020145

June 29, 2020

Drug Information

琥乙红霉素颗粒

颗粒剂

按C37H67N013计0.1g(10万单位)

化学药品

June 29, 2020

Company Information

Manufacturing Company

浙江省金华市婺城区定业新村

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥乙红霉素颗粒 - NMPA 批准文号 | MedPath